Cargando…
Patients’ access to rare neuromuscular disease therapies varies across US private insurers
BACKGROUND: The extent to which different US private insurers require their enrollees to meet the same coverage criteria before gaining access to treatment is unclear. Our objective was to scrutinize the patient access criteria imposed by US private insurers for a set of rare neuromuscular disease (...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817582/ https://www.ncbi.nlm.nih.gov/pubmed/35123543 http://dx.doi.org/10.1186/s13023-022-02182-3 |